BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, GMB-475-induced degradation of BCR-ABL at sub-micromolar levels in primary CML patient cells inhibited their proliferation, while it was not toxic to normal CD34+ cells from healthy donors.